Covetrus (CVET) Set to Announce Earnings on Tuesday

Covetrus (NASDAQ:CVET) is set to release its earnings data before the market opens on Tuesday, August 13th. Analysts expect Covetrus to post earnings of $0.16 per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Covetrus (NASDAQ:CVET) last posted its quarterly earnings results on Wednesday, May 15th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by ($0.03). The company had revenue of $941.00 million for the quarter, compared to analysts’ expectations of $993.41 million. During the same period in the previous year, the business earned $0.18 earnings per share. The firm’s quarterly revenue was down .6% on a year-over-year basis. On average, analysts expect Covetrus to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

NASDAQ:CVET opened at $23.32 on Tuesday. The business has a 50-day simple moving average of $24.29. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.82 and a quick ratio of 0.93. Covetrus has a 12-month low of $22.50 and a 12-month high of $43.83.

In other news, Director Betsy S. Atkins sold 150,845 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $27.80, for a total transaction of $4,193,491.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Timothy Ludlow sold 81,498 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $28.01, for a total transaction of $2,282,758.98. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 233,028 shares of company stock valued at $6,495,656.

CVET has been the subject of several recent analyst reports. Zacks Investment Research lowered shares of Covetrus from a “buy” rating to a “hold” rating in a report on Wednesday, July 17th. Cleveland Research initiated coverage on shares of Covetrus in a report on Friday, May 10th. They set a “hold” rating for the company. Stifel Nicolaus initiated coverage on shares of Covetrus in a report on Wednesday, May 22nd. They set a “hold” rating and a $30.00 price objective for the company. Finally, Guggenheim initiated coverage on shares of Covetrus in a report on Thursday, May 23rd. They set a “neutral” rating for the company. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $34.75.

Covetrus Company Profile

Covetrus, Inc engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.

Featured Article: Understanding Specialty Certificates of Deposit

Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.